Cargando…

2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease?

PURPOSE: Patients with peripheral arterial disease (PAD) or critical limb ischemia (CLI) require revascularization. Traditionally, endovascular therapy (EVT) is performed with iodinated contrast agent (ICM), which can provoke potential deterioration in renal function. CO2 is a safe negative contrast...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewald, Cornelia L. A., Becker, Lena S., Maschke, Sabine K., Meine, Timo C., Meyer, Bernhard C., Wacker, Frank K., Hinrichs, Jan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987613/
https://www.ncbi.nlm.nih.gov/pubmed/33330951
http://dx.doi.org/10.1007/s00270-020-02722-z
_version_ 1783668647766523904
author Dewald, Cornelia L. A.
Becker, Lena S.
Maschke, Sabine K.
Meine, Timo C.
Meyer, Bernhard C.
Wacker, Frank K.
Hinrichs, Jan B.
author_facet Dewald, Cornelia L. A.
Becker, Lena S.
Maschke, Sabine K.
Meine, Timo C.
Meyer, Bernhard C.
Wacker, Frank K.
Hinrichs, Jan B.
author_sort Dewald, Cornelia L. A.
collection PubMed
description PURPOSE: Patients with peripheral arterial disease (PAD) or critical limb ischemia (CLI) require revascularization. Traditionally, endovascular therapy (EVT) is performed with iodinated contrast agent (ICM), which can provoke potential deterioration in renal function. CO2 is a safe negative contrast agent to guide vascular procedures, but interpretation of CO2 angiography is challenging. Changes in blood flow following iodine-aided EVT are assessable with 2D-perfusion angiography (2D-PA). The aim of this study was to evaluate 2D-PA as a tool to monitor blood flow changes during CO(2)-aided EVT. MATERIAL AND METHODS: 2D-PA was performed before and after ten EVTs (nine stents; one endoprosthesis; 10/2012–02/2020) in nine patients (six men; 65 ± 10y) with Fontaine stage IIb (n = 8) and IV (n = 1). A reference ROI (ROI(INFLOW)) was placed in the artery before the targeted obstruction and a target ROI (ROI(OUTFLOW)) distally. Corresponding ROIs were used pre- and post-EVT. Time to peak (TTP), peak density (PD) and area under the curve (AUC) were computed. The reference/target ROI ratios (TTP(OUTFLOW)/TTP(INFLOW); PD(OUTFLOW)/PD(INFLOW); AUC(OUTFLOW)/AUC(INFLOW)) were calculated. RESULTS: 2D-PA was technically feasible in all cases. A significant increase of 82% in PD(OUTFLOW)/PD(INFLOW) (0.44 ± 0.4 to 0.8 ± 0.63; p = 0.002) and of 132% in AUC(OUTFLOW)/AUC(INFLOW) (0.34 ± 0.22 to 0.79 ± 0.59; p = 0.002) was seen. A trend for a decrease in TTP(OUTFLOW)/TTP(INFLOW) was observed (− 24%; 5.57 ± 3.66 s–4.25 ± 1.64 s; p = 0.6). CONCLUSION: The presented 2D-PA technique facilitates the assessment of arterial flow in CO2-aided EVTs and has the potential to simplify the assessment of immediate treatment response.
format Online
Article
Text
id pubmed-7987613
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-79876132021-04-12 2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease? Dewald, Cornelia L. A. Becker, Lena S. Maschke, Sabine K. Meine, Timo C. Meyer, Bernhard C. Wacker, Frank K. Hinrichs, Jan B. Cardiovasc Intervent Radiol Technical Note PURPOSE: Patients with peripheral arterial disease (PAD) or critical limb ischemia (CLI) require revascularization. Traditionally, endovascular therapy (EVT) is performed with iodinated contrast agent (ICM), which can provoke potential deterioration in renal function. CO2 is a safe negative contrast agent to guide vascular procedures, but interpretation of CO2 angiography is challenging. Changes in blood flow following iodine-aided EVT are assessable with 2D-perfusion angiography (2D-PA). The aim of this study was to evaluate 2D-PA as a tool to monitor blood flow changes during CO(2)-aided EVT. MATERIAL AND METHODS: 2D-PA was performed before and after ten EVTs (nine stents; one endoprosthesis; 10/2012–02/2020) in nine patients (six men; 65 ± 10y) with Fontaine stage IIb (n = 8) and IV (n = 1). A reference ROI (ROI(INFLOW)) was placed in the artery before the targeted obstruction and a target ROI (ROI(OUTFLOW)) distally. Corresponding ROIs were used pre- and post-EVT. Time to peak (TTP), peak density (PD) and area under the curve (AUC) were computed. The reference/target ROI ratios (TTP(OUTFLOW)/TTP(INFLOW); PD(OUTFLOW)/PD(INFLOW); AUC(OUTFLOW)/AUC(INFLOW)) were calculated. RESULTS: 2D-PA was technically feasible in all cases. A significant increase of 82% in PD(OUTFLOW)/PD(INFLOW) (0.44 ± 0.4 to 0.8 ± 0.63; p = 0.002) and of 132% in AUC(OUTFLOW)/AUC(INFLOW) (0.34 ± 0.22 to 0.79 ± 0.59; p = 0.002) was seen. A trend for a decrease in TTP(OUTFLOW)/TTP(INFLOW) was observed (− 24%; 5.57 ± 3.66 s–4.25 ± 1.64 s; p = 0.6). CONCLUSION: The presented 2D-PA technique facilitates the assessment of arterial flow in CO2-aided EVTs and has the potential to simplify the assessment of immediate treatment response. Springer US 2020-12-16 2021 /pmc/articles/PMC7987613/ /pubmed/33330951 http://dx.doi.org/10.1007/s00270-020-02722-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Technical Note
Dewald, Cornelia L. A.
Becker, Lena S.
Maschke, Sabine K.
Meine, Timo C.
Meyer, Bernhard C.
Wacker, Frank K.
Hinrichs, Jan B.
2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease?
title 2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease?
title_full 2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease?
title_fullStr 2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease?
title_full_unstemmed 2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease?
title_short 2D-Perfusion Angiography Using Carbon Dioxide (CO2): A Feasible Tool to Monitor Immediate Treatment Response to Endovascular Therapy of Peripheral Arterial Disease?
title_sort 2d-perfusion angiography using carbon dioxide (co2): a feasible tool to monitor immediate treatment response to endovascular therapy of peripheral arterial disease?
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987613/
https://www.ncbi.nlm.nih.gov/pubmed/33330951
http://dx.doi.org/10.1007/s00270-020-02722-z
work_keys_str_mv AT dewaldcorneliala 2dperfusionangiographyusingcarbondioxideco2afeasibletooltomonitorimmediatetreatmentresponsetoendovasculartherapyofperipheralarterialdisease
AT beckerlenas 2dperfusionangiographyusingcarbondioxideco2afeasibletooltomonitorimmediatetreatmentresponsetoendovasculartherapyofperipheralarterialdisease
AT maschkesabinek 2dperfusionangiographyusingcarbondioxideco2afeasibletooltomonitorimmediatetreatmentresponsetoendovasculartherapyofperipheralarterialdisease
AT meinetimoc 2dperfusionangiographyusingcarbondioxideco2afeasibletooltomonitorimmediatetreatmentresponsetoendovasculartherapyofperipheralarterialdisease
AT meyerbernhardc 2dperfusionangiographyusingcarbondioxideco2afeasibletooltomonitorimmediatetreatmentresponsetoendovasculartherapyofperipheralarterialdisease
AT wackerfrankk 2dperfusionangiographyusingcarbondioxideco2afeasibletooltomonitorimmediatetreatmentresponsetoendovasculartherapyofperipheralarterialdisease
AT hinrichsjanb 2dperfusionangiographyusingcarbondioxideco2afeasibletooltomonitorimmediatetreatmentresponsetoendovasculartherapyofperipheralarterialdisease